Prediction of the extent of prostate cancer by the combined use of systematic biopsy and serum level of cathepsin D

International Journal of Urology

Volumn 10, Issue 4, 2003, Pages 196-200

  Miyake, Hideaki ^a   Hara, Isao ^b   Eto, Hiroshi ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cathepsin D; Prostate cancer; PSA; Radical prostatectomy; Systematic biopsy

Indexed keywords

CATHEPSIN D; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME BLOOD LEVEL; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL;

AGED; BIOPSY, NEEDLE; CATHEPSIN D; HUMANS; MALE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0038823651     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0919-8172.2003.00603.x     Document Type: Article

References (18)

1. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J. Urol. 2000; 163: 1802-7.
2. Cooner WH, Mosley BR, Rutherfold CL Jr. et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate-specific antigen. J. Urol. 1990; 143: 1146-54.
3. Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991; 324: 1156-61.
4. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC et al. Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 1994; 44: 371-6.
5. Ravery V, Chastang C, Toublanc M, Boccon-Gibod L, Delmas V, Boccon-Gibod L. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur. Urol. 2000; 37: 449-55.
6. Cornud F, Belin X, Flam T et al. Local staging of prostate cancer by endorectal MRI using fast spin-echo sequences: Prospective correlation with pathological findings after radical prostatectomy. Br. J. Urol. 1996; 77: 843-50.
7. Hara I, Miyake H, Hara S et al. Value of serum prostate-specific antigen alpha 1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer. BJU Int. 2001; 88: 53-7.
8. Gohji K, Okamoto M, Takenaka A, Nomi M, Fujii A. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men. BJU Int. 1999; 83: 39-42.
9. Haese A, Becker C, Noldus J et al. Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus nonorgan confined growth of prostate cancer. J. Urol. 2000; 163: 1491-7.
10. Hara I, Miyake H, Hara S et al. Significance of prostate-specific antigen alpha 1-antichymotrypsin complex for diagnosis and staging of prostate cancer. Jpn. J. Clin. Oncol. 2001; 78: 506-9.
11. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eight G.H.A. Clowes Memorial Award Lecture. Cancer Res. 1990; 50: 6130-8.
12. Spyratos F, Maudelonde T, Brouillet JP et al. Cathepsin D. An important marker predicting metastasis in primary breast cancer. Lancet 1989; 2 (8672): 1115-8.
13. Maguchi S, Taniguchi N, Makita A. Elevated activity and increased mannose-6-phosphate in carbohydrate moiety of cathepsin D from human hepatoma. Cancer Res. 1988; 48: 362-7.
14. Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF Jr. Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 1997; 80: 2109-19.
15. Chambon M, Rebillard X, Rochefort H et al. Cathepsin D cytosolic assay and immunohistochemical quantification in human prostate tumors. Prostate 1994; 24: 320-5.
16. Hara I, Miyake H, Yamanaka K, Hara S, Kamidono S. Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression. Oncol. Rep. 2002; 9 (6): 1379-83.
17. International Union Against Cancer. In: Sobin LH, Wittekind CH (eds). TNM Classification of Malignant Tumors, 5th edn. John Wiley & Sons, New York, 1997: 170-3.
18. Partin AW, Carter HB, Chan DW et al. Prostate-specific antigen in the staging of localized prostate cancer: Influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol. 1990; 143: 747-52.